-   comment: Please note that the original drug to curate for this disease was aspartic acid but there is
     no evidence for it to be used as a treatment for hypokalemia unless it's a potassium salt of aspartic acid.
    directed: true
    graph:
        disease: Hypokalemia
        disease_mesh: MESH:D007008
        drug: Aspartic Acid, Potassium Salt
        drug_mesh: MESH:D001224
        drugbank: DB:DB00128
    links:
    -   key: increases abundance of
        source: MESH:D001224
        target: MESH:D011188
    -   key: negatively correlated with
        source: MESH:D011188
        target: MESH:D007008
    multigraph: true
    nodes:
    -   id: MESH:D001224
        label: Drug
        name: Aspartic Acid, Potassium Salt
    -   id: MESH:D011188
        label: ChemicalSubstance
        name: Potassium
    -   id: MESH:D007008
        label: Disease
        name: Hypokalemia
    reference: https://en.wikipedia.org/wiki/Hypokalemia https://go.drugbank.com/drugs/DB00128
-   directed: true
    graph:
        disease: Pain
        disease_mesh: MESH:D010146
        drug: Tramadol
        drug_mesh: MESH:D014147
        drugbank: DB:DB00193
    links:
    -   key: increases activity of
        source: MESH:D014147
        target: UniProt:P35372
    -   key: decreases activity of
        source: MESH:D014147
        target: UniProt:P23975
    -   key: decreases activity of
        source: MESH:D014147
        target: UniProt:P31645
    -   key: participates in
        source: UniProt:P31645
        target: GO:0051610
    -   key: participates in
        source: UniProt:P23975
        target: GO:0051620
    -   key: decreases abundance of
        source: GO:0051620
        target: MESH:D009638
    -   key: decreases abundance of
        source: GO:0051610
        target: MESH:D012701
    -   key: positively correlated with
        source: MESH:D012701
        target: GO:0060096
    -   key: positively correlated with
        source: MESH:D009638
        target: GO:0061533
    -   key: negatively regulates
        source: GO:0060096
        target: GO:0019233
    -   key: negatively regulates
        source: GO:0061533
        target: GO:0019233
    -   key: causes
        source: GO:0019233
        target: MESH:D010146
    -   key: decreases activity of
        source: UniProt:P35372
        target: UniProt:B7Z2C7
    -   key: decreases activity of
        source: UniProt:B7Z2C7
        target: UniProt:Q14654
    -   key: negatively regulates
        source: UniProt:P35372
        target: GO:0070509
    -   key: negatively regulates
        source: UniProt:Q14654
        target: GO:0099610
    -   key: positively regulates
        source: GO:0070509
        target: GO:1990793
    -   key: positively regulates
        source: GO:0070509
        target: GO:0061535
    -   key: positively correlated with
        source: GO:1990793
        target: MESH:D010146
    -   key: positively correlated with
        source: GO:0061535
        target: MESH:D010146
    -   key: positively regulates
        source: GO:0099610
        target: CL:0000198
    -   key: positively correlated with
        source: CL:0000198
        target: MESH:D010146
    multigraph: true
    nodes:
    -   id: MESH:D014147
        label: Drug
        name: Tramadol
    -   id: UniProt:P35372
        label: Protein
        name: Mu-type opioid receptor
    -   id: UniProt:B7Z2C7
        label: Protein
        name: Adenylate cyclase
    -   id: UniProt:Q14654
        label: Protein
        name: ATP-sensitive inward rectifier potassium channel 11
    -   id: GO:0070509
        label: BiologicalProcess
        name: Transmembrane calcium influx
    -   id: GO:1990793
        label: BiologicalProcess
        name: Substance P secretion, neurotransmission
    -   id: GO:0061535
        label: BiologicalProcess
        name: Glutamate secretion, neurotransmission
    -   id: GO:0099610
        label: BiologicalProcess
        name: Action potential initiation
    -   id: CL:0000198
        label: Cell
        name: Nociceptor
    -   id: UniProt:P23975
        label: Protein
        name: Sodium-dependent noradrenaline transporter
    -   id: GO:0051620
        label: BiologicalProcess
        name: Noradrenaline uptake
    -   id: MESH:D009638
        label: ChemicalSubstance
        name: Noradrenaline
    -   id: GO:0061533
        label: BiologicalProcess
        name: Norepinephrine secretion, neurotransmission
    -   id: UniProt:P31645
        label: Protein
        name: Sodium-dependent serotonin transporter
    -   id: GO:0051610
        label: BiologicalProcess
        name: Serotonin uptake
    -   id: MESH:D012701
        label: ChemicalSubstance
        name: Serotonin
    -   id: GO:0060096
        label: BiologicalProcess
        name: Serotonin secretion, neurotransmission
    -   id: GO:0019233
        label: BiologicalProcess
        name: Sensory perception of pain
    -   id: MESH:D010146
        label: Disease
        name: Pain
    reference: https://go.drugbank.com/drugs/DB00193 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811866/
     https://en.wikipedia.org/wiki/Opioid_receptor#Mechanism_of_activation
-   directed: true
    graph:
        disease: Osteoarthritis
        disease_mesh: MESH:D010003
        drug: Tramadol
        drug_mesh: MESH:D014147
        drugbank: DB:DB00193
    links:
    -   key: increases activity of
        source: MESH:D014147
        target: UniProt:P35372
    -   key: decreases activity of
        source: MESH:D014147
        target: UniProt:P23975
    -   key: decreases activity of
        source: MESH:D014147
        target: UniProt:P31645
    -   key: participates in
        source: UniProt:P31645
        target: GO:0051610
    -   key: participates in
        source: UniProt:P23975
        target: GO:0051620
    -   key: decreases abundance of
        source: GO:0051620
        target: MESH:D009638
    -   key: decreases abundance of
        source: GO:0051610
        target: MESH:D012701
    -   key: positively correlated with
        source: MESH:D012701
        target: GO:0060096
    -   key: positively correlated with
        source: MESH:D009638
        target: GO:0061533
    -   key: negatively regulates
        source: GO:0060096
        target: GO:0019233
    -   key: negatively regulates
        source: GO:0061533
        target: GO:0019233
    -   key: causes
        source: GO:0019233
        target: HP:0012531
    -   key: decreases activity of
        source: UniProt:P35372
        target: UniProt:B7Z2C7
    -   key: decreases activity of
        source: UniProt:B7Z2C7
        target: UniProt:Q14654
    -   key: negatively regulates
        source: UniProt:P35372
        target: GO:0070509
    -   key: negatively regulates
        source: UniProt:Q14654
        target: GO:0099610
    -   key: positively regulates
        source: GO:0070509
        target: GO:1990793
    -   key: positively regulates
        source: GO:0070509
        target: GO:0061535
    -   key: positively correlated with
        source: GO:1990793
        target: HP:0012531
    -   key: positively correlated with
        source: GO:0061535
        target: HP:0012531
    -   key: positively regulates
        source: GO:0099610
        target: CL:0000198
    -   key: positively correlated with
        source: CL:0000198
        target: HP:0012531
    -   key: manifestation of
        source: HP:0012531
        target: MESH:D010003
    multigraph: true
    nodes:
    -   id: MESH:D014147
        label: Drug
        name: Tramadol
    -   id: UniProt:P35372
        label: Protein
        name: Mu-type opioid receptor
    -   id: UniProt:B7Z2C7
        label: Protein
        name: Adenylate cyclase
    -   id: UniProt:Q14654
        label: Protein
        name: ATP-sensitive inward rectifier potassium channel 11
    -   id: GO:0070509
        label: BiologicalProcess
        name: Transmembrane calcium influx
    -   id: GO:1990793
        label: BiologicalProcess
        name: Substance P secretion, neurotransmission
    -   id: GO:0061535
        label: BiologicalProcess
        name: Glutamate secretion, neurotransmission
    -   id: GO:0099610
        label: BiologicalProcess
        name: Action potential initiation
    -   id: CL:0000198
        label: Cell
        name: Nociceptor
    -   id: UniProt:P23975
        label: Protein
        name: Sodium-dependent noradrenaline transporter
    -   id: GO:0051620
        label: BiologicalProcess
        name: Noradrenaline uptake
    -   id: MESH:D009638
        label: ChemicalSubstance
        name: Noradrenaline
    -   id: GO:0061533
        label: BiologicalProcess
        name: Norepinephrine secretion, neurotransmission
    -   id: UniProt:P31645
        label: Protein
        name: Sodium-dependent serotonin transporter
    -   id: GO:0051610
        label: BiologicalProcess
        name: Serotonin uptake
    -   id: MESH:D012701
        label: ChemicalSubstance
        name: Serotonin
    -   id: GO:0060096
        label: BiologicalProcess
        name: Serotonin secretion, neurotransmission
    -   id: GO:0019233
        label: BiologicalProcess
        name: Sensory perception of pain
    -   id: HP:0012531
        label: PhenotypicFeature
        name: Pain
    -   id: MESH:D010003
        label: Disease
        name: Osteoarthritis
    reference: https://go.drugbank.com/drugs/DB00193 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811866/
     https://en.wikipedia.org/wiki/Opioid_receptor#Mechanism_of_activation
-   directed: true
    graph:
        disease: Chronic pain
        disease_mesh: MESH:D059350
        drug: Tramadol
        drug_mesh: MESH:D014147
        drugbank: DB:DB00193
    links:
    -   key: increases activity of
        source: MESH:D014147
        target: UniProt:P35372
    -   key: decreases activity of
        source: MESH:D014147
        target: UniProt:P23975
    -   key: decreases activity of
        source: MESH:D014147
        target: UniProt:P31645
    -   key: participates in
        source: UniProt:P31645
        target: GO:0051610
    -   key: participates in
        source: UniProt:P23975
        target: GO:0051620
    -   key: decreases abundance of
        source: GO:0051620
        target: MESH:D009638
    -   key: decreases abundance of
        source: GO:0051610
        target: MESH:D012701
    -   key: positively correlated with
        source: MESH:D012701
        target: GO:0060096
    -   key: positively correlated with
        source: MESH:D009638
        target: GO:0061533
    -   key: negatively regulates
        source: GO:0060096
        target: GO:0019233
    -   key: negatively regulates
        source: GO:0061533
        target: GO:0019233
    -   key: causes
        source: GO:0019233
        target: MESH:D059350
    -   key: decreases activity of
        source: UniProt:P35372
        target: UniProt:B7Z2C7
    -   key: decreases activity of
        source: UniProt:B7Z2C7
        target: UniProt:Q14654
    -   key: negatively regulates
        source: UniProt:P35372
        target: GO:0070509
    -   key: negatively regulates
        source: UniProt:Q14654
        target: GO:0099610
    -   key: positively regulates
        source: GO:0070509
        target: GO:1990793
    -   key: positively regulates
        source: GO:0070509
        target: GO:0061535
    -   key: positively correlated with
        source: GO:1990793
        target: MESH:D059350
    -   key: positively correlated with
        source: GO:0061535
        target: MESH:D059350
    -   key: positively regulates
        source: GO:0099610
        target: CL:0000198
    -   key: positively correlated with
        source: CL:0000198
        target: MESH:D059350
    multigraph: true
    nodes:
    -   id: MESH:D014147
        label: Drug
        name: Tramadol
    -   id: UniProt:P35372
        label: Protein
        name: Mu-type opioid receptor
    -   id: UniProt:B7Z2C7
        label: Protein
        name: Adenylate cyclase
    -   id: UniProt:Q14654
        label: Protein
        name: ATP-sensitive inward rectifier potassium channel 11
    -   id: GO:0070509
        label: BiologicalProcess
        name: Transmembrane calcium influx
    -   id: GO:1990793
        label: BiologicalProcess
        name: Substance P secretion, neurotransmission
    -   id: GO:0061535
        label: BiologicalProcess
        name: Glutamate secretion, neurotransmission
    -   id: GO:0099610
        label: BiologicalProcess
        name: Action potential initiation
    -   id: CL:0000198
        label: Cell
        name: Nociceptor
    -   id: UniProt:P23975
        label: Protein
        name: Sodium-dependent noradrenaline transporter
    -   id: GO:0051620
        label: BiologicalProcess
        name: Noradrenaline uptake
    -   id: MESH:D009638
        label: ChemicalSubstance
        name: Noradrenaline
    -   id: GO:0061533
        label: BiologicalProcess
        name: Norepinephrine secretion, neurotransmission
    -   id: UniProt:P31645
        label: Protein
        name: Sodium-dependent serotonin transporter
    -   id: GO:0051610
        label: BiologicalProcess
        name: Serotonin uptake
    -   id: MESH:D012701
        label: ChemicalSubstance
        name: Serotonin
    -   id: GO:0060096
        label: BiologicalProcess
        name: Serotonin secretion, neurotransmission
    -   id: GO:0019233
        label: BiologicalProcess
        name: Sensory perception of pain
    -   id: MESH:D059350
        label: Disease
        name: Chronic pain
    reference: https://go.drugbank.com/drugs/DB00193 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811866/
     https://en.wikipedia.org/wiki/Opioid_receptor#Mechanism_of_activation
-   directed: true
    graph:
        disease: Hypertensive disorder
        disease_mesh: MESH:D006973
        drug: Isradipine
        drug_mesh: MESH:D017275
        drugbank: DB:DB00270
    links:
    -   key: decreases activity of
        source: MESH:D017275
        target: InterPro:IPR005446
    -   key: decreases activity of
        source: MESH:D017275
        target: InterPro:IPR000584
    -   key: decreases activity of
        source: MESH:D017275
        target: InterPro:IPR013680
    -   key: decreases activity of
        source: MESH:D017275
        target: UniProt:O95180
    -   key: positively regulates
        source: InterPro:IPR005446
        target: GO:0070509
    -   key: positively regulates
        source: InterPro:IPR000584
        target: GO:0070509
    -   key: positively regulates
        source: InterPro:IPR013680
        target: GO:0070509
    -   key: positively regulates
        source: UniProt:O95180
        target: GO:0070509
    -   key: positively regulates
        source: GO:0070509
        target: GO:0004687
    -   key: positively regulates
        source: GO:0004687
        target: GO:0006939
    -   key: positively regulates
        source: GO:0006939
        target: GO:0042310
    -   key: affects risk for
        source: GO:0042310
        target: MESH:D006973
    multigraph: true
    nodes:
    -   id: MESH:D017275
        label: Drug
        name: Isradipine
    -   id: InterPro:IPR005446
        label: GeneFamily
        name: Voltage-dependent calcium channel, L-type, alpha-1 subunit
    -   id: InterPro:IPR000584
        label: GeneFamily
        name: Voltage-dependent L-type calcium channel subunit beta
    -   id: InterPro:IPR013680
        label: GeneFamily
        name: Voltage-dependent calcium channel, alpha-2/delta subunit, conserved regio
    -   id: UniProt:O95180
        label: Protein
        name: Voltage-dependent T-type calcium channel subunit alpha-1H
    -   id: GO:0070509
        label: BiologicalProcess
        name: Calcium ion import
    -   id: GO:0004687
        label: BiologicalProcess
        name: Myosin light chain kinase activity
    -   id: GO:0006939
        label: BiologicalProcess
        name: Smooth muscle contraction
    -   id: GO:0042310
        label: BiologicalProcess
        name: Vasoconstriction
    -   id: MESH:D006973
        label: Disease
        name: Hypertensive disorder
    reference: https://go.drugbank.com/drugs/DB00270#BE0000864
-   comment: There is an evidence indicating that levonorgestrel activates progesteron receptor https://pubmed.ncbi.nlm.nih.gov/16112947/
    directed: true
    graph:
        disease: Menorrhagia
        disease_mesh: MESH:D008595
        drug: Levonorgestrel
        drug_mesh: MESH:D016912
        drugbank: DB:DB00367
    links:
    -   key: increases activity of
        source: MESH:D016912
        target: UniProt:P06401
    -   key: negatively regulates
        source: UniProt:P06401
        target: GO:0050673
    -   key: positively correlated with
        source: GO:0050673
        target: MESH:D008595
    multigraph: true
    nodes:
    -   id: MESH:D016912
        label: Drug
        name: Levonorgestrel
    -   id: UniProt:P06401
        label: Protein
        name: Progesterone receptor
    -   id: GO:0050673
        label: BiologicalProcess
        name: Epithelial cell proliferation
    -   id: MESH:D008595
        label: Disease
        name: Menorrhagia
    reference:  https://go.drugbank.com/drugs/DB00367#BE0000557 https://pubmed.ncbi.nlm.nih.gov/8671392/
-   comment: Norgestrel is composed of a racemic mixture of two stereoisomers, dextronorgestrel and levonorgestrel. However, only the levorotary enantiomer (levonorgestrel) is biologically active.
     There is an evidence indicating that levonorgestrel activates progesteron receptor https://pubmed.ncbi.nlm.nih.gov/16112947/
    directed: true
    graph:
        disease: Menorrhagia
        disease_mesh: MESH:D008595
        drug: Norgestrel
        drug_mesh: MESH:D009644
        drugbank: DB:DB09389
    links:
    -   key: increases activity of
        source: MESH:D009644
        target: UniProt:P06401
    -   key: negatively regulates
        source: UniProt:P06401
        target: GO:0050673
    -   key: positively correlated with
        source: GO:0050673
        target: MESH:D008595
    multigraph: true
    nodes:
    -   id: MESH:D009644
        label: Drug
        name: Norgestrel
    -   id: UniProt:P06401
        label: Protein
        name: Progesterone receptor
    -   id: GO:0050673
        label: BiologicalProcess
        name: Epithelial cell proliferation
    -   id: MESH:D008595
        label: Disease
        name: Menorrhagia
    reference:  https://go.drugbank.com/drugs/DB00367#BE0000557 https://pubmed.ncbi.nlm.nih.gov/8671392/
-   comment: Levonorgestrel is prescribed in combination with estradiol as a hormone therapy during menopause to prevent osteoporosis and in this case estradiol is the acive drug that prevents oseoporosis,
     while levonorgestrel is added for the protection of the endometrium
    directed: true
    graph:
        disease: Postmenopausal osteoporosis
        disease_mesh: MESH:D015663
        drug: Levonorgestrel
        drug_mesh: MESH:D016912
        drugbank: DB:DB00367
    links:
    -   key: treats
        source: MESH:D016912
        target: MESH:D015663
    multigraph: true
    nodes:
    -   id: MESH:D016912
        label: Drug
        name: Levonorgestrel
    -   id: MESH:D015663
        label: Disease
        name: Postmenopausal osteoporosis
    reference: https://go.drugbank.com/drugs/DB00367#BE0000557 https://en.wikipedia.org/wiki/Levonorgestrel#Hormone_therapy
-   comment: Norgestrel is composed of a racemic mixture of two stereoisomers, dextronorgestrel and levonorgestrel.
       However, only the levorotary enantiomer (levonorgestrel) is biologically active. Norgestrel is prescribed in combination with estradiol as a hormone therapy during menopause to prevent osteoporosis and in this case estradiol is the acive drug that prevents oseoporosis,
     while norgestrel is added for the protection of the endometrium
    directed: true
    graph:
        disease: Postmenopausal osteoporosis
        disease_mesh: MESH:D015663
        drug: Norgestrel
        drug_mesh: MESH:D009644
        drugbank: DB:DB09389
    links:
    -   key: treats
        source: MESH:D009644
        target: MESH:D015663
    multigraph: true
    nodes:
    -   id: MESH:D009644
        label: Drug
        name: Norgestrel
    -   id: MESH:D015663
        label: Disease
        name: Postmenopausal osteoporosis
    reference: https://go.drugbank.com/drugs/DB00367#BE0000557 https://en.wikipedia.org/wiki/Norgestrel#Medical_uses
-   comment: Levonorgestrel is prescribed in combination with estradiol as a hormone therapy during menopause to prevent menopausal flushing and in this case estradiol is the acive drug,
     while levonorgestrel is added for the protection of the endometrium
    directed: true
    graph:
        disease: Menopausal flushing
        disease_mesh: MESH:D019584
        drug: Levonorgestrel
        drug_mesh: MESH:D016912
        drugbank: DB:DB00367
    links:
    -   key: treats
        source: MESH:D016912
        target: MESH:D019584
    multigraph: true
    nodes:
    -   id: MESH:D016912
        label: Drug
        name: Levonorgestrel
    -   id: MESH:D019584
        label: Disease
        name: Menopausal flushing
    reference: https://go.drugbank.com/drugs/DB00367#BE0000557 https://en.wikipedia.org/wiki/Levonorgestrel#Hormone_therapy
-   comment: Norgestrel is composed of a racemic mixture of two stereoisomers, dextronorgestrel and levonorgestrel.
       However, only the levorotary enantiomer (levonorgestrel) is biologically active. Norgestrel is prescribed in combination with estradiol as a hormone therapy during menopause to menopausal flushing and in this case estradiol is the acive drug,
     while norgestrel is added for the protection of the endometrium.
    directed: true
    graph:
        disease: Menopausal flushing
        disease_mesh: MESH:D019584
        drug: Norgestrel
        drug_mesh: MESH:D009644
        drugbank: DB:DB09389
    links:
    -   key: treats
        source: MESH:D009644
        target: MESH:D019584
    multigraph: true
    nodes:
    -   id: MESH:D009644
        label: Drug
        name: Norgestrel
    -   id: MESH:D019584
        label: Disease
        name: Menopausal flushing
    reference: https://go.drugbank.com/drugs/DB00367#BE0000557 https://en.wikipedia.org/wiki/Norgestrel#Medical_uses
-   directed: true
    graph:
        disease: Allergic rhinitis
        disease_mesh: MESH:D065631
        drug: Montelukast
        drug_mesh: MESH:C093875
        drugbank: DB:DB00471
    links:
    -   key: decreases activity of
        source: MESH:C093875
        target: UniProt:Q9Y271
    -   key: positively correlated with
        source: UniProt:Q9Y271
        target: MESH:D017998
    -   key: positively regulates
        source: MESH:D017998
        target: GO:0070254
    -   key: positively regulates
        source: MESH:D017998
        target: GO:0043117
    -   key: positively regulates
        source: MESH:D017998
        target: GO:0006954
    -   key: manifestation of
        source: GO:0070254
        target: MESH:D065631
    -   key: manifestation of
        source: GO:0043117
        target: MESH:D065631
    -   key: manifestation of
        source: GO:0006954
        target: MESH:D065631
    multigraph: true
    nodes:
    -   id: MESH:C093875
        label: Drug
        name: Montelukast
    -   id: UniProt:Q9Y271
        label: Protein
        name: Cysteinyl leukotriene receptor 1
    -   id: MESH:D017998
        label: ChemicalSubstance
        name: Leukotriene D4
    -   id: GO:0070254
        label: BiologicalProcess
        name: Mucus secretion
    -   id: GO:0043117
        label: BiologicalProcess
        name: Positive regulation of vascular permeability
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response 
    -   id: MESH:D065631
        label: Disease
        name: Allergic rhinitis
    reference: https://go.drugbank.com/drugs/DB00471#BE0000705 https://en.wikipedia.org/wiki/Montelukast#Pharmacology
-   comment:  The mechanism by which felbamate exerts its anticonvulsant activity is not fully known.
    directed: true
    graph:
        disease: Epilepsy
        disease_mesh: MESH:D004827
        drug: Felbamate
        drug_mesh: MESH:C047360
        drugbank: DB:DB00949
    links:
    -   key: decreases activity of
        source: MESH:C047360
        target: UniProt:Q13224
    -   key: decreases activity of
        source: MESH:C047360
        target: UniProt:Q12879
    -   key: positively correlated with
        source: UniProt:Q13224
        target: HP:0001250
    -   key: positively correlated with
        source: UniProt:Q12879
        target: HP:0001250
    -   key: manifestation of
        source: HP:0001250
        target: MESH:D004827
    multigraph: true
    nodes:
    -   id: MESH:C047360
        label: Drug
        name: Felbamate
    -   id: UniProt:Q13224
        label: Protein
        name: Glutamate receptor ionotropic, NMDA 2B
    -   id: UniProt:Q12879
        label: Protein
        name: Glutamate receptor ionotropic, NMDA
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D004827
        label: Disease
        name: Epilepsy
    reference: https://go.drugbank.com/drugs/DB00949#BE0000417  https://pubmed.ncbi.nlm.nih.gov/32197322/
-   comment:  The mechanism by which felbamate exerts its anticonvulsant activity is not fully known.
    directed: true
    graph:
        disease: Simple partial seizure
        disease_mesh: MESH:D004828
        drug: Felbamate
        drug_mesh: MESH:C047360
        drugbank: DB:DB00949
    links:
    -   key: decreases activity of
        source: MESH:C047360
        target: UniProt:Q13224
    -   key: decreases activity of
        source: MESH:C047360
        target: UniProt:Q12879
    -   key: positively correlated with
        source: UniProt:Q13224
        target: HP:0001250
    -   key: positively correlated with
        source: UniProt:Q12879
        target: HP:0001250
    -   key: manifestation of
        source: HP:0001250
        target: MESH:D004828
    multigraph: true
    nodes:
    -   id: MESH:C047360
        label: Drug
        name: Felbamate
    -   id: UniProt:Q13224
        label: Protein
        name: Glutamate receptor ionotropic, NMDA 2B
    -   id: UniProt:Q12879
        label: Protein
        name: Glutamate receptor ionotropic, NMDA
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D004828
        label: Disease
        name: Simple partial seizure
    reference: https://go.drugbank.com/drugs/DB00949#BE0000417  https://pubmed.ncbi.nlm.nih.gov/32197322/
-   comment: The mechanism by which felbamate exerts its anticonvulsant activity is not fully known.
    directed: true
    graph:
        disease: Lennox-Gastaut syndrome
        disease_mesh: MESH:D065768
        drug: Felbamate
        drug_mesh: MESH:C047360
        drugbank: DB:DB00949
    links:
    -   key: decreases activity of
        source: MESH:C047360
        target: UniProt:Q13224
    -   key: decreases activity of
        source: MESH:C047360
        target: UniProt:Q12879
    -   key: positively correlated with
        source: UniProt:Q13224
        target: HP:0001250
    -   key: positively correlated with
        source: UniProt:Q12879
        target: HP:0001250
    -   key: manifestation of
        source: HP:0001250
        target: MESH:D065768
    multigraph: true
    nodes:
    -   id: MESH:C047360
        label: Drug
        name: Felbamate
    -   id: UniProt:Q13224
        label: Protein
        name: Glutamate receptor ionotropic, NMDA 2B
    -   id: UniProt:Q12879
        label: Protein
        name: Glutamate receptor ionotropic, NMDA
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D065768
        label: Disease
        name: Lennox-Gastaut syndrome
    reference: https://go.drugbank.com/drugs/DB00949#BE0000417  https://pubmed.ncbi.nlm.nih.gov/32197322/
-   directed: true
    graph:
        disease: Osteitis deformans
        disease_mesh: MESH:D010001
        drug: Tiludronic acid
        drug_mesh: MESH:C058651
        drugbank: DB:DB01133
    links:
    -   key: decreases abundance of
        source: MESH:C058651
        target: MESH:D000255
    -   key: located in
        source: MESH:D000255
        target: CL:0000092
    -   key: participates in
        source: CL:0000092
        target: GO:0046849
    -   key: causes
        source: GO:0046849
        target: MESH:D010001
    multigraph: true
    nodes:
    -   id: MESH:C058651
        label: Drug
        name: Tiludronic acid
    -   id: MESH:D000255
        label: ChemicalSubstance
        name: Adenosine Triphosphate
    -   id: CL:0000092
        label: Cell
        name: Osteoclast
    -   id: GO:0046849
        label: BiologicalProcess
        name: Bone remodeling
    -   id: MESH:D010001
        label: Disease
        name: Osteitis deformans
    reference: https://en.wikipedia.org/wiki/Tiludronic_acid https://go.drugbank.com/drugs/DB01133
      https://en.wikipedia.org/wiki/Paget%27s_disease_of_bone
-   comment: Potentially non-efficacious https://pubmed.ncbi.nlm.nih.gov/26615034/
    directed: true
    graph:
        disease: Common cold
        disease_mesh: MESH:D003139
        drug: Clofedanol
        drug_mesh: MESH:C010432
        drugbank: DB:DB04837
    links:
    -   key: decreases activity of
        source: MESH:C010432
        target: UniProt:P35367
    -   key: participates in
        source: UniProt:P35367
        target: GO:0071420
    -   key: positively correlated with
        source: GO:0071420
        target: GO:0006954
    -   key: caused by
        source: GO:0006954
        target: NCBITaxon:10239
    -   key: causes
        source: NCBITaxon:10239
        target: MESH:D003139
    multigraph: true
    nodes:
    -   id: MESH:C010432
        label: Drug
        name: Clofedanol
    -   id: UniProt:P35367
        label: Protein
        name: Histamine H1 receptor
    -   id: GO:0071420
        label: BiologicalProcess
        name: Cellular response to histamine
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: NCBITaxon:10239
        label: OrganismTaxon
        name: Viruses
    -   id: MESH:D003139
        label: Disease
        name: Common cold
    reference: https://go.drugbank.com/drugs/DB04837
-   directed: true
    graph:
        disease: Allergic rhinitis
        disease_mesh: MESH:D065631
        drug: Clofedanol
        drug_mesh: MESH:C010432
        drugbank: DB:DB04837
    links:
    -   key: negatively regulates
        source: MESH:C010432
        target: UniProt:P35367
    -   key: positively correlated with
        source: UniProt:P35367
        target: MESH:D006632
    -   key: positively regulates
        source: MESH:D006632
        target: GO:0071159
    -   key: positively regulates
        source: GO:0071159
        target: GO:0006954
    -   key: located in
        source: GO:0006954
        target: UBERON:0000004
    -   key: affected by
        source: UBERON:0000004
        target: MESH:D065631
    multigraph: true
    nodes:
    -   id: MESH:C010432
        label: Drug
        name: Clofedanol
    -   id: UniProt:P35367
        label: Protein
        name: Histamine H1 receptor
    -   id: MESH:D006632
        label: ChemicalSubstance
        name: Histamine
    -   id: GO:0071159
        label: CellularComponent
        name: NF-kappaB complex
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: UBERON:0000004
        label: GrossAnatomicalStructure
        name: Nose
    -   id: MESH:D065631
        label: Disease
        name: Allergic rhinitis
    reference: https://go.drugbank.com/drugs/DB04837
-   directed: true
    graph:
        disease: Rhinitis
        disease_mesh: MESH:D012220
        drug: Clofedanol
        drug_mesh: MESH:C010432
        drugbank: DB:DB04837
    links:
    -   key: negatively regulates
        source: MESH:C010432
        target: UniProt:P35367
    -   key: positively correlated with
        source: UniProt:P35367
        target: MESH:D006632
    -   key: positively regulates
        source: MESH:D006632
        target: GO:0071159
    -   key: positively regulates
        source: GO:0071159
        target: GO:0006954
    -   key: located in
        source: GO:0006954
        target: UBERON:0000004
    -   key: affected by
        source: UBERON:0000004
        target: MESH:D012220
    multigraph: true
    nodes:
    -   id: MESH:C010432
        label: Drug
        name: Clofedanol
    -   id: UniProt:P35367
        label: Protein
        name: Histamine H1 receptor
    -   id: MESH:D006632
        label: ChemicalSubstance
        name: Histamine
    -   id: GO:0071159
        label: CellularComponent
        name: NF-kappaB complex
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: UBERON:0000004
        label: GrossAnatomicalStructure
        name: Nose
    -   id: MESH:D012220
        label: Disease
        name: Rhinitis
    reference: https://go.drugbank.com/drugs/DB04837
-   comment: Clofedanol suppresses the cough reflex by a direct effect on the cough center in the medulla of the brain
    directed: true
    graph:
        disease: Cough
        disease_mesh: MESH:D003371
        drug: Clofedanol
        drug_mesh: MESH:C010432
        drugbank: DB:DB04837
    links:
    -   key: negatively regulates
        source: MESH:C010432
        target: GO:0060004
    -   key: positively correlated with
        source: GO:0060004
        target: MESH:D003371
    multigraph: true
    nodes:
    -   id: MESH:C010432
        label: Drug
        name: Clofedanol
    -   id: GO:0060004
        label: BiologicalProcess
        name: Reflex
    -   id: MESH:D003371
        label: Disease
        name: Cough
    reference: https://go.drugbank.com/drugs/DB04837 https://pubchem.ncbi.nlm.nih.gov/compound/2795
-   directed: true
    graph:
        disease: Vasomotor rhinitis
        disease_mesh: MESH:D012223
        drug: Clofedanol
        drug_mesh: MESH:C010432
        drugbank: DB:DB04837
    links:
    -   key: negatively regulates
        source: MESH:C010432
        target: UniProt:P35367
    -   key: positively correlated with
        source: UniProt:P35367
        target: MESH:D006632
    -   key: increases abundance of
        source: MESH:D006632
        target: MESH:D013373
    -   key: participates in
        source: MESH:D013373
        target: MESH:D020078
    -   key: contributes to
        source: MESH:D020078
        target: MESH:D012223
    multigraph: true
    nodes:
    -   id: MESH:C010432
        label: Drug
        name: Clofedanol
    -   id: UniProt:P35367
        label: Protein
        name: Histamine H1 receptor
    -   id: MESH:D006632
        label: ChemicalSubstance
        name: Histamine
    -   id: MESH:D013373
        label: ChemicalSubstance
        name: Substance P
    -   id: MESH:D020078
        label: Disease
        name: Neurogenic Inflammation
    -   id: MESH:D012223
        label: Disease
        name: Vasomotor rhinitis
    reference: https://en.wikipedia.org/wiki/Rhinitis#Nonallergic_rhinitis https://go.drugbank.com/drugs/DB04837
       https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764847/
-   comment: The precise mechanism of brivaracetam's anti-epileptogenic activity is unknown.
     It is thought that brivaracetam binds to SV2A and causes the reduction in the rate of vesicle release including release of excitatory neurotransmitters.
    directed: true
    graph:
        disease: Partial seizure
        disease_mesh: MESH:D004828
        drug: Brivaracetam
        drug_mesh: MESH:C482793
        drugbank: DB:DB05541
    links:
    -   key: negatively regulates
        source: MESH:C482793
        target: UniProt:Q7L0J3
    -   key: negatively regulates
        source: MESH:C482793
        target: GO:0005248
    -   key: participates in
        source: UniProt:Q7L0J3
        target: GO:0007269
    -   key: positively correlated with
        source: GO:0005248
        target: HP:0001250
    -   key: correlated with
        source: GO:0007269
        target: MESH:D004828
    -   key: manifestation of
        source: HP:0001250
        target: MESH:D004828
    multigraph: true
    nodes:
    -   id: MESH:C482793
        label: Drug
        name: Brivaracetam
    -   id: UniProt:Q7L0J3
        label: Protein
        name: Synaptic vesicle glycoprotein 2A
    -   id: GO:0005248
        label: MolecularActivity
        name: Voltage-gated sodium channel activity
    -   id: GO:0007269
        label: BiologicalProcess
        name: Neurotransmitter secretion
    -   id: HP:0001250
        label: PhenotypicFeature
        name: Seizure
    -   id: MESH:D004828
        label: Disease
        name: Partial seizure
    reference: https://en.wikipedia.org/wiki/Brivaracetam#Pharmacology https://go.drugbank.com/drugs/DB05541
      https://pubmed.ncbi.nlm.nih.gov/27768878/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888813/
-   directed: true
    graph:
        disease: Impotence
        disease_mesh: MESH:D007172
        drug: Moxisylyte
        drug_mesh: MESH:D013948
        drugbank: DB:DB09205
    links:
    -   key: decreases activity of
        source: MESH:D013948
        target: GO:0004936
    -   key: positively regulates
        source: GO:0004936
        target: GO:0042310
    -   key: negatively correlated with
        source: GO:0042310
        target: GO:0008015
    -   key: negatively correlated with
        source: GO:0008015
        target: MESH:D007172
    multigraph: true
    nodes:
    -   id: MESH:D013948
        label: Drug
        name: Moxisylyte
    -   id: GO:0004936
        label: BiologicalProcess
        name: Alpha-adrenergic receptor activity
    -   id: GO:0042310
        label: BiologicalProcess
        name: Vasoconstriction
    -   id: GO:0008015
        label: BiologicalProcess
        name: Blood circulation
    -   id: MESH:D007172
        label: Disease
        name: Impotence
    reference: https://go.drugbank.com/drugs/DB09205#BE0004888
-   directed: true
    graph:
        disease: Raynaud's disease
        disease_mesh: MESH:D011928
        drug: Moxisylyte
        drug_mesh: MESH:D013948
        drugbank: DB:DB09205
    links:
    -   key: decreases activity of
        source: MESH:D013948
        target: GO:0004936
    -   key: positively regulates
        source: GO:0004936
        target: GO:0042310
    -   key: negatively correlated with
        source: GO:0042310
        target: GO:0008015
    -   key: negatively correlated with
        source: GO:0008015
        target: MESH:D011928
    multigraph: true
    nodes:
    -   id: MESH:D013948
        label: Drug
        name: Moxisylyte
    -   id: GO:0004936
        label: BiologicalProcess
        name: Alpha-adrenergic receptor activity
    -   id: GO:0042310
        label: BiologicalProcess
        name: Vasoconstriction
    -   id: GO:0008015
        label: BiologicalProcess
        name: Blood circulation
    -   id: MESH:D011928
        label: Disease
        name: Raynaud's disease
    reference: https://go.drugbank.com/drugs/DB09205#BE0004888 https://en.wikipedia.org/wiki/Raynaud_syndrome
